CO4960663A1 - Fumarato de 2-(-3-(4-(2-t-butil-6-trifluorometilpirimidin- 4-il)piperazin-1-il) propilmecapto)pirimidin-4-ol - Google Patents
Fumarato de 2-(-3-(4-(2-t-butil-6-trifluorometilpirimidin- 4-il)piperazin-1-il) propilmecapto)pirimidin-4-olInfo
- Publication number
- CO4960663A1 CO4960663A1 CO98046527A CO98046527A CO4960663A1 CO 4960663 A1 CO4960663 A1 CO 4960663A1 CO 98046527 A CO98046527 A CO 98046527A CO 98046527 A CO98046527 A CO 98046527A CO 4960663 A1 CO4960663 A1 CO 4960663A1
- Authority
- CO
- Colombia
- Prior art keywords
- piperazin
- acid salt
- fumaric acid
- trifluorometilpirimidin
- pumimidate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Sal de ácido fumárico de 2-{3-[4-(2-t-butil-6-trifluorome-tilpirimidin-4-il)piperazin-1-il]propilmercapto} pirimidin-4-ol de la fórmula y las formas tautómeras, solvatos e hidratos de la misma. Medicamento que contiene la sal de ácido fumárico o una forma tautómera, un solvato o un hidrato de la misma de acuerdo con la cláusula 1, CARACTERIZADO porque puede administrarse, en caso necesario, junto con portadores y/o sustancias auxiliares fisiológicamente aceptables. Sal de ácido fumárico o una forma tautómera, un solvato o hidrato de la misma de acuerdo con la claúsula 1 utilizada para preparar un medicamento para el tratamiento de enfermedades que responden a la acción de ligandos de dopamina D3 .
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19735410A DE19735410A1 (de) | 1997-08-14 | 1997-08-14 | 2-{3-[4-(2-t-Butyl-6-trifluormethylpyrimidin-4-yl)piperazin-1-yl]propylmercapto}pyrimidin-4-ol-fumarat |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4960663A1 true CO4960663A1 (es) | 2000-09-25 |
Family
ID=7839072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98046527A CO4960663A1 (es) | 1997-08-14 | 1998-08-13 | Fumarato de 2-(-3-(4-(2-t-butil-6-trifluorometilpirimidin- 4-il)piperazin-1-il) propilmecapto)pirimidin-4-ol |
Country Status (25)
Country | Link |
---|---|
US (1) | US20010020022A1 (es) |
EP (2) | EP2272833A1 (es) |
JP (1) | JP4444492B2 (es) |
KR (1) | KR100571945B1 (es) |
CN (1) | CN1267286A (es) |
AR (1) | AR016605A1 (es) |
AT (1) | ATE525362T1 (es) |
AU (1) | AU749575B2 (es) |
BG (1) | BG104122A (es) |
BR (1) | BR9811177A (es) |
CA (1) | CA2301297A1 (es) |
CO (1) | CO4960663A1 (es) |
DE (1) | DE19735410A1 (es) |
ES (1) | ES2374156T3 (es) |
HU (1) | HUP0003710A3 (es) |
ID (1) | ID24639A (es) |
IL (1) | IL134246A (es) |
NO (1) | NO314935B1 (es) |
NZ (1) | NZ502675A (es) |
PL (1) | PL201927B1 (es) |
SK (1) | SK1182000A3 (es) |
TR (1) | TR200000406T2 (es) |
TW (1) | TW467912B (es) |
WO (1) | WO1999009015A1 (es) |
ZA (1) | ZA987239B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE402704T1 (de) * | 2000-03-27 | 2008-08-15 | Abbott Gmbh & Co Kg | Dopamin-d3-rezeptor-liganden zur behandlung von sucht |
DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
EP1778684B1 (en) * | 2004-08-09 | 2009-12-16 | Abbott GmbH & Co. KG | 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
CN102887860B (zh) * | 2012-09-29 | 2015-07-01 | 上海泰坦科技有限公司 | 4-氯-6-三氟甲基嘧啶类化合物的制备方法 |
JP6448541B2 (ja) | 2012-10-11 | 2019-01-09 | サザン リサーチ インスティテュート | アミノアルキルピペラジンの尿素及びアミド誘導体並びにその使用 |
US9376396B2 (en) | 2012-10-22 | 2016-06-28 | AbbVie Deutschland GmbH & Co. KG | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
-
1997
- 1997-08-14 DE DE19735410A patent/DE19735410A1/de not_active Withdrawn
-
1998
- 1998-08-12 TW TW087113230A patent/TW467912B/zh not_active IP Right Cessation
- 1998-08-12 AR ARP980103980A patent/AR016605A1/es not_active Application Discontinuation
- 1998-08-13 CO CO98046527A patent/CO4960663A1/es unknown
- 1998-08-13 ZA ZA9807239A patent/ZA987239B/xx unknown
- 1998-08-14 IL IL13424698A patent/IL134246A/en not_active IP Right Cessation
- 1998-08-14 CA CA002301297A patent/CA2301297A1/en not_active Abandoned
- 1998-08-14 AT AT98946343T patent/ATE525362T1/de active
- 1998-08-14 JP JP2000509698A patent/JP4444492B2/ja not_active Expired - Lifetime
- 1998-08-14 BR BR9811177-9A patent/BR9811177A/pt not_active IP Right Cessation
- 1998-08-14 SK SK118-2000A patent/SK1182000A3/sk unknown
- 1998-08-14 AU AU93426/98A patent/AU749575B2/en not_active Ceased
- 1998-08-14 EP EP10179278A patent/EP2272833A1/de not_active Withdrawn
- 1998-08-14 KR KR1020007001435A patent/KR100571945B1/ko not_active IP Right Cessation
- 1998-08-14 PL PL338603A patent/PL201927B1/pl unknown
- 1998-08-14 ID IDW20000266A patent/ID24639A/id unknown
- 1998-08-14 EP EP98946343A patent/EP1003728B1/de not_active Expired - Lifetime
- 1998-08-14 US US09/485,460 patent/US20010020022A1/en not_active Abandoned
- 1998-08-14 WO PCT/EP1998/005178 patent/WO1999009015A1/de not_active Application Discontinuation
- 1998-08-14 CN CN98808156A patent/CN1267286A/zh active Pending
- 1998-08-14 ES ES98946343T patent/ES2374156T3/es not_active Expired - Lifetime
- 1998-08-14 NZ NZ502675A patent/NZ502675A/en not_active IP Right Cessation
- 1998-08-14 HU HU0003710A patent/HUP0003710A3/hu unknown
- 1998-08-14 TR TR2000/00406T patent/TR200000406T2/xx unknown
-
2000
- 2000-02-03 BG BG104122A patent/BG104122A/xx unknown
- 2000-02-10 NO NO20000665A patent/NO314935B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001515070A (ja) | 2001-09-18 |
IL134246A0 (en) | 2001-04-30 |
ID24639A (id) | 2000-07-27 |
NZ502675A (en) | 2001-06-29 |
NO20000665D0 (no) | 2000-02-10 |
IL134246A (en) | 2002-11-10 |
ATE525362T1 (de) | 2011-10-15 |
DE19735410A1 (de) | 1999-02-18 |
KR20010022833A (ko) | 2001-03-26 |
HUP0003710A2 (hu) | 2001-10-28 |
TW467912B (en) | 2001-12-11 |
HUP0003710A3 (en) | 2002-01-28 |
PL201927B1 (pl) | 2009-05-29 |
CN1267286A (zh) | 2000-09-20 |
NO20000665L (no) | 2000-02-10 |
TR200000406T2 (tr) | 2000-05-22 |
AR016605A1 (es) | 2001-07-25 |
JP4444492B2 (ja) | 2010-03-31 |
PL338603A1 (en) | 2000-11-06 |
SK1182000A3 (en) | 2000-09-12 |
KR100571945B1 (ko) | 2006-04-18 |
WO1999009015A1 (de) | 1999-02-25 |
EP2272833A1 (de) | 2011-01-12 |
BR9811177A (pt) | 2000-07-25 |
AU749575B2 (en) | 2002-06-27 |
BG104122A (en) | 2000-11-30 |
US20010020022A1 (en) | 2001-09-06 |
CA2301297A1 (en) | 1999-02-25 |
EP1003728A1 (de) | 2000-05-31 |
ES2374156T3 (es) | 2012-02-14 |
NO314935B1 (no) | 2003-06-16 |
ZA987239B (en) | 2000-02-14 |
AU9342698A (en) | 1999-03-08 |
EP1003728B1 (de) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016351A1 (es) | FORMA CRISTALINA BETA DE LA SAL DE ADICIoN DE ÁCIDO METANSULFoNICO DE 4-(4-METILPIPERAZIN-1-ILMETIL)-N-[4-METIL-3-(4-PIRIDIN-3-IL) PIRIMIDIN-2-ILAMINO) FENIL] BENZAMIDA, COMPOSICIoN FARMACÉUTICA, USO DE LA FORMA CRISTALINA PARA LA PREPARACIoN DE UN AGENTE FARMACOLoGICO, Y PROCESOS PARA LA PREPARACIo | |
DE69109284D1 (de) | Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe. | |
ECSP055746A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
ES2155473T3 (es) | Composicion veterinaria que contiene un inhibidor de las bombas de protones. | |
HU9400727D0 (en) | 1-[(4-chloro-phenyl)-phenyl-methyl]-4-[(4-methyl-phenyl)-sulfonyl]-piperazine enanthiomeres and process for producing them | |
DK0799209T3 (da) | Sulfonamider | |
AU6473601A (en) | Gabapentin analogues for sleep disorders | |
AU1826202A (en) | Treatment of gastrointestinal stromal tumors | |
BR0012901A (pt) | Medicamentos de ß - carbolina | |
BR0312873A (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil] benzamida para tratamento de doenças associadas com ret cinase mutante | |
CO4960663A1 (es) | Fumarato de 2-(-3-(4-(2-t-butil-6-trifluorometilpirimidin- 4-il)piperazin-1-il) propilmecapto)pirimidin-4-ol | |
ES2191942T3 (es) | Nueva utilizacion de un antagonista especifico de los receptores 5ht2a. | |
ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
ATE260655T1 (de) | Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen | |
ES2191908T3 (es) | 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido. | |
DE69941897D1 (de) | Arzneimittel für nicht-cardiogene diastolische dysfunktion | |
AR023452A1 (es) | Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor | |
ATE294572T1 (de) | Verwendung von gepirone metabolite zur erstellungs eines medicaments zur behandlung von neurologischer krankheiten | |
NO941084L (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
GB9126874D0 (en) | Medicaments | |
BR9910185A (pt) | Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
ATE247462T1 (de) | Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist | |
NO975790D0 (no) | Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer | |
AR026242A1 (es) | Empleo de 2-amino-3,4-dihidro-quinazolinas para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas por estadosisquemicos |